Pearson Rachael A, Wicha Sebastian G, Okour Malek
Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA.
Department of Clinical Pharmacy, Institute of Pharmacy, University of Hamburg, Hamburg, Germany.
J Clin Pharmacol. 2023 Feb;63(2):151-165. doi: 10.1002/jcph.2128. Epub 2022 Sep 11.
Combination therapies have become increasingly researched and used in the treatment and management of complex diseases due to their ability to increase the chances for better efficacy and decreased toxicity. To evaluate drug combinations in drug development, pharmacokinetic and pharmacodynamic interactions between drugs in combination can be quantified using mathematical models; however, it can be difficult to deduce which models to use and how to use them to aid in clinical trial simulations to simulate the effect of a drug combination. This review paper aims to provide an overview of the various methods used to evaluate combination drug interaction for use in clinical trial development and a practical guideline on how combination modeling can be used in the settings of clinical trials.
由于联合疗法能够提高疗效并降低毒性,增加治疗复杂疾病的机会,因此在复杂疾病的治疗和管理中,对联合疗法的研究和应用越来越多。在药物研发中评估药物组合时,可使用数学模型对联合用药之间的药代动力学和药效学相互作用进行量化;然而,很难推断出使用哪些模型以及如何使用这些模型来辅助临床试验模拟,以模拟药物组合的效果。本文综述旨在概述用于评估联合药物相互作用以用于临床试验开发的各种方法,以及关于如何在临床试验中使用联合建模的实用指南。